HIV Risk Reduction and Drug Abuse Treatment in Iran
Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
A randomized, double blind clinical trial comparing buprenorphine and naltrexone maintenance
treatment when combined with drug abuse and HIV risk reduction counseling (DC-HIV) for heroin
and opium addicts in Iran.